It is always with much emotion that I address myself to a room full of healthcare professionals desiring to know more about the recent research carried out by Natural Source International in the line of work of Mirko Beljanski. This pleasure was recently given to me in Switzerland, where I shared a conference with Dr. Eric Kienner. The audience, who clearly appreciated the quality of the recently developed research and the publications that have just confirmed them, were extremely receptive and asked many good questions.
This enthusiasm was a satisfying contrast to the information recently announced on 60 Minutes uncovering a fraudulent clinical trial conducted at Duke University. The goal of this clinical trial, funded by U.S. taxpayers over the past four years, was to test the genetic profile of patients affected by cancer, and to adapt the protocols of chemotherapy in function of their profiles. The idea could have been interesting, but it turned out to be a fraud and now Duke University, and some of its doctors, are being prosecuted.
It is worrying that we haven’t seen any progress so early in the personalization of official cancer treatments. “Randomized” chemotherapy (that is to say the opposite of personalized), and radiotherapy without protection remain “the gold standard” while, obviously, the public is looking for gentler, more friendly, formulas that offer synergistic action with the classic treatments, which are supported by quality publications.
For many years I have been trying to attract attention to the necessity of protecting our bodies from radiation.The French media has relayed the results of an American study conducted by researchers at Yale that was published in CANCER magazine.This study creates the link between dental x-rays and brain tumors.(more…)
At TEDGlobal 2012, Mina Bissell, a researcher associated with the Lawrence Berkeley National Laboratory gave a talk on how the microenvironment can trigger and activate cancer genes, which immediately caught the media’s attention. This “big idea” (according to Mrs. Bissell’s own words) is actually more then 30 years old.
Well before Mrs. Bissell first presented her discovery, a French researcher named Mirko Beljanski, a Doctor of Science working at the Pasteur Institute, the recipient of the Charles Leopold Mayer award for his work on the role of RNA in the process of protein synthesis discovered and published on the very same thing!
I have recently received the following email. I believe it may be of interest to a number of you.
“Dear Sylvie,
Your company manufactures the Beljanski products such as Pao V, Pao V FM, Rovol V, RealBuild, Ginkgo V and many others in the Targetage line. I’m writing to you today because I would like to learn more about them and to ask whether it is possible to use them preventively against cancer in short, yearly cycles, while reinforcing the immune system with the Targetage supplements. As you probably imagine, my main question is what to take and how to take it. (more…)
Recently, a local New York newspaper, “AM New York” featured a full-page advertisement for the Lustgarten Foundation, which together with Cablevision (cable TV), claims to support pancreatic cancer research (curePC.org).
Seeing this made me consider sending them a file with the results of a recent study by Kansas University. The findings of this study done on extracts of Pao Pereira and Rauwolfia Vomitoria on pancreatic and ovarian cancer cell conducted with the financial support of the Beljanski Foundation, were published in the BMC journal of Complementary & Alternative Medicine in 2012. (June 12, 2012).
The abstract submitted by Dr. Yu J, J Drisko and Chen Q indicates that:
The two plant extracts of Pao pereira and Rauwolfia vomitoria serve to neutralize cancer cells (independant of chemotherapy), even ones resistant to antimiotics (cases in which chemotherapy is considered ineffective).
The healthy cells remained undamaged, thus demonstrating the safety of the plant extracts prepared and examined with the Beljanski method.
The research team also studied the behavior of the extracts when combined with chemotherapy. The synergy of action first demonstrated by Mirko Beljanski during his work as a researcher, has again been confirmed on both pancreatic and ovarian cancer cells.
Since these results are extremely promising, new and coming from a renown institution, we will soon see if the media is interested in working for the common good by promoting research based on natural products, or cares only for further subsidizing the research departments of pharmaceutical companies. All too often the generous contributions of people that want to help are used to fund studies and patents for synthetic and often toxic molecules, while at the same time generating big profits for those involved.
Couple of years back, I was contacted by a foundation claiming to support research against autism. I sent them some observations of a physician who noticed a significant improvement in the condition of autistic children whom she had recommended the elimination of gluten, lactose and sugar from their diet combined with the removal of heavy metals and supplementation with Pao Pereira, Omega 3 and Beljanski RNA fragments. According to the doctor, in only a few weeks the improvement was spectacular, especially given the relatively low cost of the treatment. I believed that results like these should immediately draw attention of an autism research foundation….. and I was wrong! After receiving a polite little note acknowledging the receipt of the file and saying that my email is very interesting and will receive full consideration… complete silence. I have received nothing from the foundation, except further requests for financial support, and not even one report on the research that the money is supposedly being spent on.
Abstract: Anti-cancer activity of extracts from Rauwolfia vomitoria and Pao Pereira
With the Beljanski Foundation, you know the money you contribute goes to funding life-saving research. You can read the results of the studies published by Columbia University, Cancer Treatment Centers of America (CTCA), or Kansas University yourself. The donations made in France, with CIRIS, or USA, with the Beljanski Foundation, Inc., are tax deductible in those countries, so you also know you will receive the maximum deduction possible, while at the same time supporting an important cause.
Personally, whenever I am approached by a charity asking me for money, I always ask them where are their results and publications and explain why I choose to give to the Beljanski Foundation.
It is always with much emotion that I address myself to a room full of healthcare professionals desiring to know more about the recent research carried out by Natural Source International in the line of work of Mirko Beljanski. This pleasure was recently given to me in Switzerland, where I shared a conference with Dr. Eric Kienner. The audience, who clearly appreciated the quality of the recently developed research and the publications that have just confirmed them, were extremely receptive and asked many good questions.
This enthusiasm was a satisfying contrast to the information recently announced on 60 Minutes uncovering a fraudulent clinical trial conducted at Duke University. The goal of this clinical trial, funded by U.S. taxpayers over the past four years, was to test the genetic profile of patients affected by cancer, and to adapt the protocols of chemotherapy in function of their profiles. The idea could have been interesting, but it turned out to be a fraud and now Duke University, and some of its doctors, are being prosecuted.
It is worrying that we haven’t seen any progress so early in the personalization of official cancer treatments. “Randomized” chemotherapy (that is to say the opposite of personalized), and radiotherapy without protection remain “the gold standard” while, obviously, the public is looking for gentler, more friendly, formulas that offer synergistic action with the classic treatments, which are supported by quality publications.
Sylvie Beljanski
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
This enthusiasm was a satisfying contrast to the information recently announced on 60 Minutes uncovering a fraudulent clinical trial conducted at Duke University. The goal of this clinical trial, funded by U.S. taxpayers over the past four years, was to test the genetic profile of patients affected by cancer, and to adapt the protocols of chemotherapy in function of their profiles. The idea could have been interesting, but it turned out to be a fraud and now Duke University, and some of its doctors, are being prosecuted.
